SNBIF (SanBio Co) Short-Term Debt: $0.82 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SNBIF SanBio Co Ltd SNBIF
18 GF Score
Price $16.45
! 1 Warning Sign
View Full Analysis

What is SanBio Co Short-Term Debt?

SanBio Co SNBIF 18 Short-Term Debt is $0.82 Mil as of Jan. 2026. GuruFocus rates SNBIF with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

SanBio Co's Short-Term Debt for the quarter that ended in Jan. 2026 was $0.82 Mil.

SanBio Co's quarterly Short-Term Debt declined from Jul. 2025 ($1.79 Mil) to Oct. 2025 ($1.30 Mil) and declined from Oct. 2025 ($1.30 Mil) to Jan. 2026 ($0.82 Mil).

SanBio Co's annual Short-Term Debt declined from Jan. 2024 ($1.83 Mil) to Jan. 2025 ($1.71 Mil) and declined from Jan. 2025 ($1.71 Mil) to Jan. 2026 ($0.82 Mil).

SanBio Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

SanBio Co Short-Term Debt Related Terms

SanBio Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for SanBio Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SanBio Co Short-Term Debt Chart

SanBio Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.46 2.05 1.83 1.71 0.82

SanBio Co Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 1.79 1.30 0.82 0.39
SNBIF
18GF Score
SanBio Co Ltd SNBIF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.82 Mil mean?
SanBio Co (SNBIF) has a Short-Term Debt of $0.82 Mil as of Jan. 2026.
Is SanBio Co's Short-Term Debt too high?
SanBio Co's current Short-Term Debt is $0.82 Mil. Overall, SanBio Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does SanBio Co's Short-Term Debt compare to VRTX and REGN?
SanBio Co's Short-Term Debt of $0.82 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. SanBio Co's current Short-Term Debt is $0.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SanBio Co stock overvalued right now?
SanBio Co (SNBIF) has a current Short-Term Debt of $0.82 Mil. The current Short-Term Debt is $0.82 Mil. SanBio Co's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For SanBio Co (SNBIF), the current Short-Term Debt is $0.82 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SanBio Co Business Description

Other Exchanges 4592:Japan
Address 8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
18GF Score

Get the complete analysis for SNBIF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.45
Price